Recombinant prion protein for high-throughput prion diagnosis

Due not least to the BSE-crisis in Great Britian and the new variant of Creutzfeldt-Jakob disease (vCJD) a great need for a reliable diagnostic method of prion proteins exists, especially for the discrimination of prion cases from other neurodegenerative diseases. The present invention provides a method for the purification of recombinant prion proteins (rPrP), which are suitable to be used in the currently accepted detection method (Real-time quaking induced conversion, RT-QuIC) and lead to faster, more specific and overall more reliable results. Therefore, a “ready-to use protein” is provided for the detection of prion protein in blood, brain and cerebrospinal fluid (CSF).

Further information: PDF

Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0

Contact
Peer Biskup

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.